|
US3700612A
(en)
|
1971-06-23 |
1972-10-24 |
Tenneco Chem |
Aqueous surface-coating compositions containing hydroxyalkyl ethers of galactomannan gums as thickeners
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8422653D0
(en)
|
1984-09-07 |
1984-10-10 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5370872A
(en)
|
1991-08-12 |
1994-12-06 |
Swiss Serum And Vaccine Institute Berne |
Escherichia coliO-polysaccharide-protein conjugate vaccine
|
|
EP0625910B1
(en)
|
1992-02-11 |
2003-07-23 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
DK0616034T3
(da)
|
1993-03-05 |
2005-02-21 |
Wyeth Corp |
Plasmid til fremstilling af CRM-protein og diphtheria toxin
|
|
EP0720485B1
(en)
|
1993-09-22 |
2003-11-19 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
|
|
AUPM399594A0
(en)
|
1994-02-21 |
1994-03-17 |
Csl Limited |
Antigenic preparation for treatment or prevention of helicobacter infection
|
|
FI102976B
(fi)
|
1994-02-28 |
1999-03-31 |
Valtion Teknillinen |
Menetelmä lisäkeittokemikaalien tuottamiseksi sekä käyttämiseksi sulfa attiselluloosaprosessissa
|
|
DE69628418T2
(de)
|
1995-03-22 |
2004-04-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
AU743114B2
(en)
|
1997-04-01 |
2002-01-17 |
Corixa Corporation |
Aqueous immunologic adjuvant compositions of monophosphoryl lipid A
|
|
US6858211B1
(en)
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
ES2284287T3
(es)
|
1998-10-16 |
2007-11-01 |
Glaxosmithkline Biologicals S.A. |
Sistemas adyuvantes y vacunas.
|
|
WO2001078777A2
(en)
|
2000-04-13 |
2001-10-25 |
Mossman, Sally |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
|
|
AU2001253568A1
(en)
|
2000-04-18 |
2001-10-30 |
Dan C. Deborde |
Lipopolysaccharide-conjugate vaccine for sepsis treatment
|
|
RU2189253C1
(ru)
|
2001-04-09 |
2002-09-20 |
Государственный научный центр прикладной микробиологии |
Диагностикум для идентификации escherichia coli o157 : h7 и способ его получения
|
|
US6676958B2
(en)
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
DK1481057T3
(da)
|
2002-03-07 |
2006-05-15 |
Eidgenoess Tech Hochschule |
System og fremgangsmåde til fremstilling af rekombinante glycosylerede proteiner i en prokaryot vært
|
|
AU2003901008A0
(en)
|
2003-03-04 |
2003-03-20 |
Anadis Ltd |
Composition for the treatment and prevention of bacterial infections
|
|
CN1324134C
(zh)
|
2003-12-22 |
2007-07-04 |
南开大学 |
对大肠杆菌o81型的o－抗原特异的核苷酸
|
|
AU2005229434B2
(en)
|
2004-03-30 |
2010-09-30 |
Nsgene A/S |
Therapeutic use of a growth factor, NsG33
|
|
ES2535084T3
(es)
|
2005-05-11 |
2015-05-05 |
Eth Zurich |
Proteínas N-glicosiladas recombinantes procedentes de células procariotas
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
CA2646891A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
|
ATE539079T1
(de)
|
2006-03-23 |
2012-01-15 |
Novartis Ag |
Imidazochinoxalinverbindungen als immunmodulatoren
|
|
JP4791866B2
(ja)
|
2006-03-24 |
2011-10-12 |
国立大学法人秋田大学 |
下痢原性大腸菌感染症の判別に用いられる固相等
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
WO2009036379A2
(en)
|
2007-09-14 |
2009-03-19 |
Adimab, Inc. |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
CN102037004A
(zh)
|
2008-01-08 |
2011-04-27 |
生物种属学股份公司 |
使用寡糖基转移酶的多肽的糖缀合
|
|
SI2257307T1
(sl)
|
2008-02-20 |
2018-09-28 |
Glaxosmithkline Biologicals S.A. |
Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
|
|
MX2011011376A
(es)
|
2009-04-27 |
2012-04-20 |
Immuron Ltd |
Preparacion de inmunoglobulina enriquecida con anti-lps, para utilizarse en tratamiento y/o profilaxis de un trastorno patologico.
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
NO2501406T3
(enExample)
|
2009-11-19 |
2018-05-19 |
|
|
|
MX381912B
(es)
|
2010-07-16 |
2025-03-13 |
Adimab Llc |
Colecciones de anticuerpos.
|
|
US20130273098A1
(en)
|
2010-12-10 |
2013-10-17 |
Jeffrey T. Blue |
Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
|
|
CA2847621A1
(en)
|
2011-09-06 |
2013-03-14 |
Glycovaxyn Ag |
Bioconjugate vaccines made in prokaryotic cells
|
|
US9932598B2
(en)
|
2012-08-02 |
2018-04-03 |
The Regents Of The University Of California |
Metabolic engineering of microbial organisms
|
|
PT2885007T
(pt)
|
2012-08-16 |
2018-12-10 |
Pfizer |
Processos e composições de glicoconjugação
|
|
WO2014037585A1
(en)
|
2012-09-10 |
2014-03-13 |
Glycovaxyn Ag |
Bioconjugates comprising modified antigens and uses thereof
|
|
KR20150068998A
(ko)
|
2012-10-12 |
2015-06-22 |
글리코박신 아게 |
숙주 세포 변형 방법
|
|
EP2917351B1
(en)
|
2012-11-07 |
2018-12-19 |
GlaxoSmithKline Biologicals S.A. |
Production of recombinant vaccine in e. coli by enzymatic conjugation
|
|
RU2672053C2
(ru)
|
2012-12-20 |
2018-11-09 |
Пфайзер Инк. |
Способ гликоконъюгации
|
|
CA2896157A1
(en)
|
2012-12-27 |
2014-07-03 |
Glycovaxyn Ag |
Methods and compositions relating to crm197
|
|
HUE038915T2
(hu)
|
2013-01-17 |
2018-12-28 |
Arsanis Biosciences Gmbh |
MDR E. colira fajlagos antitest
|
|
CU24377B1
(es)
|
2013-05-18 |
2018-12-05 |
Aduro Biotech Inc |
Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
|
|
CN103495161B
(zh)
|
2013-10-08 |
2019-06-18 |
江苏康泰生物医学技术有限公司 |
一种多元肺炎球菌荚膜多糖-蛋白质结合物的混合物及其制备方法
|
|
BR112016007727A8
(pt)
|
2013-10-11 |
2018-01-30 |
Glycovaxyn Ag |
célula hospedeira, e, método para produzir uma proteína n-glicosilada.
|
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
|
CN106163550A
(zh)
|
2013-12-04 |
2016-11-23 |
格林考瓦因有限公司 |
通过大肠杆菌中合成的糖蛋白疫苗预防金黄色葡萄球菌感染
|
|
KR102301188B1
(ko)
|
2014-02-06 |
2021-09-13 |
엑스4 파마슈티컬스 (오스트리아) 게엠베하 |
이. 콜라이 특이성 항체 서열
|
|
NZ723328A
(en)
|
2014-02-24 |
2018-01-26 |
Glycovaxyn Ag |
Compositions comprising e. coli o25b antigen, uses thereof and methods of manufacture
|
|
MX378857B
(es)
|
2014-04-17 |
2025-03-10 |
Glaxosmithkline Biologicals Sa |
Celulas huespedes modificadas y usos de las mismas.
|
|
CN105695497B
(zh)
|
2014-11-27 |
2019-09-24 |
中国人民解放军军事医学科学院生物工程研究所 |
一种细菌多糖修饰的重组融合蛋白的制备方法及其应用
|
|
SI3240895T1
(sl)
|
2014-12-30 |
2022-04-29 |
Glaxosmithkline Biologicals S.A. |
Sestavki in postopki za glikozilacijo proteinov
|
|
TWI715617B
(zh)
|
2015-08-24 |
2021-01-11 |
比利時商葛蘭素史密斯克藍生物品公司 |
對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
|
|
GB201518668D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Immunogenic Comosition
|
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
|
AR109621A1
(es)
|
2016-10-24 |
2018-12-26 |
Janssen Pharmaceuticals Inc |
Formulaciones de vacunas contra glucoconjugados de expec
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
US11260119B2
(en)
*
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
JP7551618B2
(ja)
|
2018-12-12 |
2024-09-17 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Ｏ－結合型グリコシル化のための修飾キャリアタンパク質
|
|
CR20210522A
(es)
*
|
2019-03-18 |
2021-12-17 |
Janssen Pharmaceuticals Inc |
Bioconjugados de antígenos–polisacáridos de e. coli, métodos de producción y métodos de utilización de los mismos
|
|
IL286467B2
(en)
|
2019-03-18 |
2026-02-01 |
Janssen Pharmaceuticals Inc |
Methods for producing bioconjugates of polysaccharides E. coli o-antigen, preparations thereof and methods for using them
|
|
FR3098334B1
(fr)
|
2019-07-05 |
2021-07-23 |
Airbus Operations Sas |
Procédé et système de surveillance d’un état de conscience d’un opérateur dans un poste de pilotage d’un aéronef
|
|
MX2023011697A
(es)
*
|
2021-04-01 |
2023-10-19 |
Janssen Pharmaceuticals Inc |
Produccion de bioconjugados o18 de e. coli.
|